Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial

Dawson, L. A., Winter, K. A., Knox, J. J., Zhu, A. X., Krishnan, S., Guha, C., Kachnic, L. A., Gillin, M. T., Hong, T. S., Craig, T. D., Williams, T. M., Hosni, A., Chen, E., Noonan, A. M., Koay, E. J., Sinha, R., Lock, M. I., Ohri, N., Dorth, J. A., … Crane, C. H. (2024). Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.5403
Authors:
Laura A Dawson
Kathryn A Winter
Jennifer J Knox
Andrew X Zhu
Sunil Krishnan
Chandan Guha
Lisa A Kachnic
Michael T Gillin
Theodore S Hong
Timothy D Craig
Terence M Williams
Ali Hosni
Eric Chen
Anne M Noonan
Eugene J Koay
Rishi Sinha
Michael I Lock
Nitin Ohri
Jennifer A Dorth
Guila Delouya
Anand Swaminath
Jennifer Moughan
Christopher H Crane
Affiliated Authors:
Lisa A Kachnic
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1001/jamaoncol.2024.5403
PMID:
39699905
DOI:
10.1001/jamaoncol.2024.5403
Journal:
JAMA Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: